The impact of age-related differences in blood pressure ( 
| INTRODUCTION
The worldwide prevalence of hypertension in 2008 was 40% of adults 25 years and older.
1 Hypertension is estimated to cause approximately 13% of all annual deaths. 2 In light of the world's population growth and aging, hypertension is a global public health issue. 3 The prevalence of prehypertension including normal and highnormal blood pressure (BP) has varied from 15% to 59% in previous studies. [4] [5] [6] [7] [8] [9] [10] [11] Prehypertension is associated with a higher risk of the future development of hypertension [12] [13] [14] [15] [16] [17] and cardiovascular disease (CVD) [18] [19] [20] [21] [22] compared with optimal BP in the general population. The reported rates of progression to hypertension during 2 to 4 years of follow-up were 5% to 7% for individuals with optimal BP, 15% to 21% for those with normal BP, and 31% to 43% for people with highnormal BP. [13] [14] [15] Predictors of hypertension subtypes are young age and male sex for isolated diastolic hypertension (IDH) and old age and female sex for isolated systolic hypertension (ISH). 23 A 2015 study in younger and middle-aged adults reported that the relative risk for CVD mortality compared with optimal-normal BP among men was highest for the subjects with systolic diastolic hypertension (SDH), followed by IDH, high-normal BP, and ISH, whereas in women, the risk was highest for those with SDH, followed by ISH. 24 In addition, the impact of slightly higher systolic BP (SBP) in comparison with diastolic BP (DBP) for developing future hypertension, which may result in future CVD, may be different even among individuals with normal BP or high-normal BPs. To our knowledge, however, no study has examined whether SBP or DBP is associated with the risk for the new onset of hypertension by age in subjects with prehypertension (separately for normal BP and high normal BP).
We conducted the present study to assess both the progression rate to hypertension at an 8-year follow-up and the impacts of sex-and age-related differences in BP components on the rate of progression to hypertension among normotensive subjects who underwent an annual health checkup. were excluded from the baseline data. We also excluded the subjects (n=20 487) who did not undergo a further health checkup during the period from 2006 to 2013 (ie, as a follow-up). Figure 1 shows the flow chart of the study subjects. The study was conducted according to the principles of the Declaration of Helsinki.
| METHODS

| Study population
| Baseline and follow-up measurement
The BP of each subject was measured once by medical staff using a standard mercury sphygmomanometer after the subject had rested for 5 minutes in a seated position. When the SBP was ≥140 mm Hg or the DBP was ≥90 mm Hg, the BP was measured again after the subject took several deep breaths. After this second measurement, the lower BP values were used. We defined the initiation of antihypertensive medications as an answer "yes" to the question "Do you take an antihypertensive drug?" Self-reported hypertension was defined as the subject stating that he or she had been told by a physician that he or she had hypertension. 
| Follow-up and outcomes
In accordance with the Industrial Safety and Health Law in Japan, the 
| Statistical analyses
Values are expressed as the mean±standard deviation or percentages. We tested the statistical differences in the characteristics of the subjects classified by BP category with the t test for the slope in linear regression models of the mean values for continuous variables and with the Cochran-Armitage test for trends for categorical variables. First, we estimated the cumulative incidence of hypertension at the 8-year follow-up by the Kaplan-Meier method among the overall subjects (n=93 303). We then estimated the hazard ratios (HRs) and 95% confidence intervals (CIs) of the risk of developing hypertension at the 8-year follow-up by using multiple Cox proportional hazards models adjusted for BP category at baseline and covariates among the subjects (n=57 725; sample sizes reduced due to missing data). The sex-and age-stratified analysis (age <50 vs ≥50 years) was conducted separately. All statistical analyses were performed with SAS version 9.3 software (SAS Institute Inc, Cary, NC, USA). All reported P values were two-tailed, and those <.05
were considered significant.
| RESULTS
| Baseline characteristics
There were 93 303 subjects (48 773 men, 44 530 women; mean age 41.1 years) in the present study. A higher prevalence of men; older age; greater BMI and pulse rate values; higher levels of total cholesterol, triglyceride, low-density lipoprotein cholesterol, and hemoglobin A 1c ; lower levels of high-density lipoprotein cholesterol and estimated glomerular filtration rate; and a higher prevalence of proteinuria were apparent with increases in BP category (Tables S1 to S3 ).
| Incidence of hypertension during 8 years of follow-up
During 
. The incidence of hypertension in the subjects with IDHN was significantly higher than that in the subjects with ISHN (P<.001), and the incidence in the subjects with IDN was significantly higher than that in the subjects with ISN (P<.001; Figure 3B ).
The age-specific cumulative incidence of hypertension by BP category at baseline is shown in Figure 4 . The incidence of hypertension for all BP categories at baseline was significantly higher in the subjects 50 years and older compared with those younger than 50 years (all P<.005; Figure 4 ). Among the subjects younger than 50 years, the incidence of hypertension in subjects with IDHN was significantly F I G U R E 2 Incidence of new-onset hypertension (HT) by age group at baseline and by HT subtype. The number on top of each bar is the incidence of new-onset HT higher than in those with ISHN (P<.001), and the incidence in the IDN subjects was significantly higher than that in the subjects with ISN (P<.001; Figure 4A ,B).
Among the subjects 50 years and older, the incidence of hypertension in those with IDHN was similar to that in the subjects with ISHN (P=.018), and the incidence in the IDN group was similar to that in the ISN group (P=.031), although there were statistically but not clinically significant differences (Figure 4C,D) . There were no essential sex differences in these associations (data not shown).
| Risk of developing hypertension
The HRs and 95% CI values for developing hypertension according to BP category at baseline and obtained using a Cox proportional hazards model are plotted in Figure 5 and summarized in Table S4 . In the overall analysis adjusted for age, sex, BMI, pulse rate, total cholesterol, high-and low-density lipoprotein cholesterol, and proteinuria, the BP category at baseline compared with optimal BP was significantly associated with the development of hypertension (P for trend <.001). In the age-stratified analysis adjusted for sex, BMI, pulse rate, total cholesterol, high-and low-density lipoprotein cholesterol, and proteinuria, the HR for developing hypertension by BP category at baseline compared with optimal BP was significantly greater in the subjects younger than 50 years compared with those 50 years and older (BP category by age interaction P<.01).
Among the subjects younger than 50 years, significant differences in the risk of developing hypertension were found between the IDHN and ISHN groups (P<.001) and between the IDN and ISN groups (P<.001; Figure 5 ). Among the older subjects (≥50 years), significant differences in the risk of developing hypertension were revealed between IDHN and ISHN (P=.013) and between IDN and ISN (P=.005), although these were statistically but not clinically significant 
| DISCUSSION
| Major findings
In this 8-year follow-up study of 93 303 Japanese subjects aged 18 to 88 years with no hypertension at baseline, representing 457 396 person-years, the major findings were that the effect of DBP was greater than that of SBP on the risk of developing hypertension associated with normal and high-normal BP compared with optimal BP in the subjects younger than 50 years. The hypertension incidence in our overall population is consistent with prior reports.
| Prevalence of prehypertension and hypertension
In previous studies, the prevalence of prehypertension varied from 15% to 59%, and the prevalence of hypertension varied from 22% to 44%. [4] [5] [6] [7] [8] [9] [10] [11] The prevalence of prehypertension in the present study (32%) was lower than that reported in Nigeria, 4 China, 5 and Iran, which ranged from 52% to 59%, and it was higher than the 15% reported in Turkey. 7 In the other regions and countries, such as Asia [8] [9] [10] and the United States, 11 the prevalence of prehypertension ranged from 31% to 33%, which is comparable to our present finding. However, the prevalence of hypertension in the present study (16%) is lower than those of some previous studies. 
| Rate of progression to hypertension by BP category
Longitudinal associations between baseline BP and the risk for hypertension have been suggested in previous studies. [12] [13] [14] [15] Hansen and colleagues 12 reported that among 2357 Danes aged 30 to 60 years, the crude progression rates to hypertension from optimal, normal, and high-normal BP during a median of 10.9 years were 10%, 37%, and 58%, respectively. In other studies, the rates of progression to hypertension during 2-to 4-year follow-up were 5% to 7%, 15% to 21%, and 31% to 43% for optimal, normal, and high-normal BP, respectively. [13] [14] [15] Here, we derived 8-year rates of hypertension assuming a constant risk (data not shown), and our results (6%, 32%, and 63% for optimal, normal, and high-normal BP, respectively) are consistent with the previous studies.
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| Age-related risk of a new-onset hypertension by BP category
In the present study, the risk of developing hypertension increased with the BP category at baseline (P for trend <.001). In the agestratified analysis, the risk of developing hypertension in accord with the BP category at baseline compared with optimal BP was higher in the subjects younger than 50 years than in those 50 years and older (BP category by age interaction P<.01). This is because the incidence of hypertension with optimal BP in our older group was increased via the aging effect. Thus, the relative risk was higher in the younger subjects than in the older subjects, although the absolute risk was higher in the older subjects compared with the younger subjects.
Several studies investigated the relationship between BP category at baseline and the risk of developing hypertension by age in a multivariate analysis. 13, 16, 17 In the Framingham Heart Study, Vasan and colleagues 13 showed that among 9845 participants aged 35 to 94 years, the odds ratios for developing hypertension among F I G U R E 5 Hazard ratio (HR) and 95% confidence interval (CI) for new-onset hypertension by blood pressure (BP) category at baseline and by overall (adjusted for age, sex, body mass index, pulse rate, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and proteinuria), and age group (<50 or ≥50 years, adjusted for sex, body mass index, pulse rate, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and proteinuria). *P values were calculated using isolated systolic high-normal BP as reference. †P values were calculated using isolated systolic normal BP as reference normal and high-normal BP subjects compared with optimum BP subjects over the 4-year interval were higher in the subjects aged 35 to 64 years (normal BP: odds ratio, 4.1; high-normal BP: odds ratio, 17 showed that among 2048 subjects aged 35 to 74 years (divided into four 10-year age brackets), the tendency of the relative risk of developing hypertension at a 7-year follow-up declined with the increase in age at baseline.
| Effect of DBP vs SBP on the risk of developing hypertension
To our knowledge, the present study is the first to show that the ef- 
| Hemodynamic mechanisms
We observed that increased DBP constituted a risk for developing hypertension in subjects younger than 50 years, whereas in the subjects 50 years and older, increased SBP was the risk factor. Although our study could not address the mechanism explaining why the factors of BP elevation differ between younger and older subjects, a plausible explanation might be found in the previous reports. The elevation of DBP is closely related to increased vascular resistance caused by sympathetic nervous activation, which decreases with age. 28 Regarding younger subjects, the population-based Coronary Artery Risk Development in Young Adults (CARDIA) study of subjects aged 18 to 30 years showed that increased heart rate was an independent predictor for increased DBP. 29 Conversely, mainly increased vascular stiffness contributes to elevated BP in elderly subjects. This is because an increase in stiffness of the large arteries is accompanied by early wave reflection, which results in a significant augmentation of central SBP in late systole and further adds to the increased cardiac afterload. 30 The result of this phenomenon could explain the increase in SBP and decrease in DBP in the elderly population. Moreover, recent studies showed that increased SBP variability, which is more closely associated with vascular stiffness, 31,32 was related to age, whereas DBP variability showed no relation to age.
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| Study strengths and limitations
The strengths of this study are its very large sample size, the longitudinal follow-up period, and the uniform manner of data collection at a single medical center. However, there were several limitations due to the characteristics of the population and the measurement of the study indices. First, the subjects were not a population sample, and they were generally healthy individuals undergoing a health checkup.
Second, the subjects were comprised of members of organizations and employees of companies in Tokyo who might be categorized as middle-class, who might be healthier than the general population in Japan. In addition, there were few subjects older than 70 years.
Therefore, the study could have underestimated the incidence of hypertension. Third, a single measure of BP and biochemical measurements by standard methods in each period might not be accurate, which might lead to a misclassification of BP and risk factors.
Fourth, because we did not have information about some known and important CVD risk factors such as smoking, alcohol consumption, and physical activity, we could not adjust the analysis for those potential confounding effects. Finally, since the health checkup was conducted only once every year, it is possible that during this interval some subjects had severe disease without the detection of hypertension.
| CONCLUSIONS
The novelty of our study is that it clarified the differential age-related impacts of BP components on new-onset hypertension in a large prospective design. In the subjects younger than 50 years, the effect of DBP was much more powerful (by approximately twofold) than that of SBP on the risk of developing hypertension associated with normal and high-normal BP compared with optimal BP, and thus reducing DBP is important to prevent hypertension, whereas in our subjects 50 years and older with normal or high-normal BP, the effects of DBP and SBP were similar. Clinicians should pay much more attention to slight increases in DBP and begin early nonpharmacological intervention in younger adults with DBP >80 mm Hg.
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